戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 he high rate of acute rejection, sepsis, and posttransplantation lymphoproliferative disorder.
2 ronic rejection and the other as a result of posttransplantation lymphoproliferative disorder.
3 ing off immunosuppression for treatment of a posttransplantation lymphoproliferative disorder.
4 d neoplastic bowel obstruction, three due to posttransplantation lymphoproliferative disorder and one
5                        The manifestations of posttransplantation lymphoproliferative disorders are my
6    Here we report an unusual presentation of posttransplantation lymphoproliferative disorder as unil
7 e patient who was treated with CsA developed posttransplantation lymphoproliferative disorder during
8 e two episodes of Epstein Barr virus-related posttransplantation lymphoproliferative disorder, one of
9                                              Posttransplantation lymphoproliferative disorders (PT-LP
10 oma, and also distinguished untreated, EBV(+)posttransplantation lymphoproliferative disorder (PTLD)
11                                              Posttransplantation lymphoproliferative disorder (PTLD)
12 e increased risk of Epstein-Barr virus (EBV) posttransplantation lymphoproliferative disorder (PTLD)
13 following rituximab-based chemotherapy for a posttransplantation lymphoproliferative disorder (PTLD)
14                                              Posttransplantation lymphoproliferative disorder (PTLD)
15 t died from Epstein-Barr virus (EBV)-related posttransplantation lymphoproliferative disorder (PTLD)
16                                              Posttransplantation lymphoproliferative disorder (PTLD)
17                                              Posttransplantation lymphoproliferative disorder (PTLD)
18       Five cases of allograft involvement by posttransplantation lymphoproliferative disorder (PTLD)
19 terature describing the relationship between posttransplantation lymphoproliferative disorder (PTLD)
20                                              Posttransplantation lymphoproliferative disorder (PTLD)
21                                              Posttransplantation lymphoproliferative disorder (PTLD),
22 oproliferation consistent with a polymorphic posttransplantation lymphoproliferative disorder (PTLD).
23                                              Posttransplantation lymphoproliferative disorders (PTLD)
24                                       EBV(-) posttransplantation lymphoproliferative disorders (PTLDs
25  271 centers worldwide to define patterns of posttransplantation lymphoproliferative disorders (PTLDs
26                                              Posttransplantation lymphoproliferative disorders (PTLDs
27 ffective for the treatment of EBV-associated posttransplantation lymphoproliferative disorders (PTLDs
28  1 year for belatacept, but the incidence of posttransplantation lymphoproliferative disorder was hig

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。